Mouse models of allergic asthma: acute and chronic allergen challenge
Top Cited Papers
- 21 November 2008
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 1 (4-5) , 213-220
- https://doi.org/10.1242/dmm.000323
Abstract
Asthma is defined as a chronic inflammatory disease of the airways; however, the underlying physiological and immunological processes are not fully understood. Animal models have been used to elucidate asthma pathophysiology, and to identify and evaluate novel therapeutic targets. Several recent review articles (Epstein, 2004; Lloyd, 2007; Boyce and Austen, 2005; Zosky and Sly, 2007) have discussed the potential value of these models. Allergen challenge models reproduce many features of clinical asthma and have been widely used by investigators; however, the majority involve acute allergen challenge procedures. It is recognised that asthma is a chronic inflammatory disease resulting from continued or intermittent allergen exposure, usually via inhalation, and there has been a recent focus on developing chronic allergen exposure models, predominantly in mice. Here, we review the acute and chronic exposure mouse models, and consider their potential role and impact in the field of asthma research.Keywords
This publication has 85 references indexed in Scilit:
- Steroid-Resistant Neutrophilic Inflammation in a Mouse Model of an Acute Exacerbation of AsthmaAmerican Journal of Respiratory Cell and Molecular Biology, 2008
- Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNature Medicine, 2008
- Animal models of chronic experimental asthma — strategies for the identification of new therapeutic targetsJournal of Occupational Medicine and Toxicology, 2008
- Endothelin, PAF and thromboxane A2 in allergic pulmonary hyperreactivity in miceProstaglandins, Leukotrienes & Essential Fatty Acids, 2007
- Co-Administration of Vaccination with DNA Encoding T Cell Epitope on the Der p and BCG Inhibited Airway Remodeling in a Murine Model of Chronic AsthmaJournal of Asthma, 2006
- TNF-α induces the late-phase airway hyperresponsiveness and airway inflammation through cytosolic phospholipase A2 activationJournal of Allergy and Clinical Immunology, 2005
- Therapeutic administration of Budesonide ameliorates allergen‐induced airway remodellingClinical and Experimental Allergy, 2005
- Repeated Aerosol Allergen Exposure Suppresses Inflammation in B-Cell-Deficient Mice with Established Allergic AsthmaInternational Archives of Allergy and Immunology, 2004
- Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthmaJournal of Allergy and Clinical Immunology, 2001
- Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate AsthmaAnnals of Allergy, Asthma & Immunology, 1997